149 related articles for article (PubMed ID: 35390234)
1. A hypothesis that Notopterol may be effective in COVID-19 via JAK/STAT and other signaling pathways.
Nazari-Khanamiri F; Ghasemnejad-Berenji M
J Basic Clin Physiol Pharmacol; 2023 May; 34(3):405-407. PubMed ID: 35390234
[TBL] [Abstract][Full Text] [Related]
2. The Natural Compound Notopterol Binds and Targets JAK2/3 to Ameliorate Inflammation and Arthritis.
Wang Q; Zhou X; Yang L; Zhao Y; Chew Z; Xiao J; Liu C; Zheng X; Zheng Y; Shi Q; Liang Q; Wang Y; Wang H
Cell Rep; 2020 Sep; 32(11):108158. PubMed ID: 32937124
[TBL] [Abstract][Full Text] [Related]
3. The Many Faces of JAKs and STATs Within the COVID-19 Storm.
Grant AH; Estrada A; Ayala-Marin YM; Alvidrez-Camacho AY; Rodriguez G; Robles-Escajeda E; Cadena-Medina DA; Rodriguez AC; Kirken RA
Front Immunol; 2021; 12():690477. PubMed ID: 34326843
[TBL] [Abstract][Full Text] [Related]
4. Janus kinase signaling as risk factor and therapeutic target for severe SARS-CoV-2 infection.
Solimani F; Meier K; Ghoreschi K
Eur J Immunol; 2021 May; 51(5):1071-1075. PubMed ID: 33675065
[TBL] [Abstract][Full Text] [Related]
5. Insights into forsythia honeysuckle (Lianhuaqingwen) capsules: A Chinese herbal medicine repurposed for COVID-19 pandemic.
Liang C; Hui N; Liu Y; Qiao G; Li J; Tian L; Ju X; Jia M; Liu H; Cao W; Yu P; Li H; Ren X
Phytomed Plus; 2021 May; 1(2):100027. PubMed ID: 35399819
[TBL] [Abstract][Full Text] [Related]
6. Coronavirus Disease-2019 Treatment Strategies Targeting Interleukin-6 Signaling and Herbal Medicine.
Dzobo K; Chiririwa H; Dandara C; Dzobo W
OMICS; 2021 Jan; 25(1):13-22. PubMed ID: 32857671
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the IFN-α JAK/STAT Pathway by MERS-CoV and SARS-CoV-1 Proteins in Human Epithelial Cells.
Zhang Y; Gargan S; Roche FM; Frieman M; Stevenson NJ
Viruses; 2022 Mar; 14(4):. PubMed ID: 35458397
[TBL] [Abstract][Full Text] [Related]
8. Potential effect of Maxing Shigan decoction against coronavirus disease 2019 (COVID-19) revealed by network pharmacology and experimental verification.
Li Y; Chu F; Li P; Johnson N; Li T; Wang Y; An R; Wu D; Chen J; Su Z; Gu X; Ding X
J Ethnopharmacol; 2021 May; 271():113854. PubMed ID: 33513419
[TBL] [Abstract][Full Text] [Related]
9. Baricitinib, a drug with potential effect to prevent SARS-COV-2 from entering target cells and control cytokine storm induced by COVID-19.
Zhang X; Zhang Y; Qiao W; Zhang J; Qi Z
Int Immunopharmacol; 2020 Sep; 86():106749. PubMed ID: 32645632
[TBL] [Abstract][Full Text] [Related]
10. Targeting JAK-STAT Signaling to Control Cytokine Release Syndrome in COVID-19.
Luo W; Li YX; Jiang LJ; Chen Q; Wang T; Ye DW
Trends Pharmacol Sci; 2020 Aug; 41(8):531-543. PubMed ID: 32580895
[TBL] [Abstract][Full Text] [Related]
11. JAK inhibitor blocks COVID-19 cytokine-induced JAK/STAT/APOL1 signaling in glomerular cells and podocytopathy in human kidney organoids.
Nystrom SE; Li G; Datta S; Soldano KL; Silas D; Weins A; Hall G; Thomas DB; Olabisi OA
JCI Insight; 2022 Jun; 7(11):. PubMed ID: 35472001
[TBL] [Abstract][Full Text] [Related]
12. Active metabolites and potential mechanisms of
Liu P; Tang W; Zhao D; Zhou P; Hu K
Front Pharmacol; 2023; 14():1185100. PubMed ID: 37719850
[No Abstract] [Full Text] [Related]
13. The potential involvement of JAK-STAT signaling pathway in the COVID-19 infection assisted by ACE2.
Luo J; Lu S; Yu M; Zhu L; Zhu C; Li C; Fang J; Zhu X; Wang X
Gene; 2021 Feb; 768():145325. PubMed ID: 33253796
[TBL] [Abstract][Full Text] [Related]
14. JAK inhibition as a new treatment strategy for patients with COVID-19.
Huang J; Zhou C; Deng J; Zhou J
Biochem Pharmacol; 2022 Aug; 202():115162. PubMed ID: 35787993
[TBL] [Abstract][Full Text] [Related]
15. A Network-Based Analysis Reveals the Mechanism Underlying Vitamin D in Suppressing Cytokine Storm and Virus in SARS-CoV-2 Infection.
Ahmed F
Front Immunol; 2020; 11():590459. PubMed ID: 33362771
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of COVID-19 Causing ARDS: Exploring the Possibility of Preventing and Treating SARS-CoV-2.
Zheng J; Miao J; Guo R; Guo J; Fan Z; Kong X; Gao R; Yang L
Front Cell Infect Microbiol; 2022; 12():931061. PubMed ID: 35774402
[TBL] [Abstract][Full Text] [Related]
17. Loss of sarcomeric proteins via upregulation of JAK/STAT signaling underlies interferon-γ-induced contractile deficit in engineered human myocardium.
Zhan RZ; Rao L; Chen Z; Strash N; Bursac N
Acta Biomater; 2021 May; 126():144-153. PubMed ID: 33705988
[TBL] [Abstract][Full Text] [Related]
18. Coronavirus disease 2019 and pityriasis rosea: A review of the immunological connection.
Borgia F; Li Pomi F; Alessandrello C; Vaccaro M; Pioggia G; Gangemi S
J Dermatol; 2022 Oct; 49(10):948-956. PubMed ID: 35675487
[TBL] [Abstract][Full Text] [Related]
19. A comprehensive evaluation of the immune system response and type-I Interferon signaling pathway in hospitalized COVID-19 patients.
Soltani-Zangbar MS; Parhizkar F; Ghaedi E; Tarbiat A; Motavalli R; Alizadegan A; Aghebati-Maleki L; Rostamzadeh D; Yousefzadeh Y; Jadideslam G; Farid SS; Roshangar L; Mahmoodpoor A; Heris JA; Miahipour A; Yousefi M
Cell Commun Signal; 2022 Jul; 20(1):106. PubMed ID: 35842705
[TBL] [Abstract][Full Text] [Related]
20. An endogenously activated antiviral state restricts SARS-CoV-2 infection in differentiated primary airway epithelial cells.
Broadbent L; Bamford CGG; Lopez Campos G; Manzoor S; Courtney D; Ali A; Touzelet O; McCaughey C; Mills K; Power UF
PLoS One; 2022; 17(4):e0266412. PubMed ID: 35436306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
